Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Feb 8, 2020

32106_dirs_2020-02-07_5cc47831-4369-41e9-8d64-431d39d25247.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-01-08

Reporting Person: DE GREEF RODERICK (CFO & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-08 Common Stock M 10000 $1.8099 Acquired 35859 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-08 Employee Stock Option $1.8099 M 10000 Disposed 2026-05-03 Common Stock (10000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option $1.7600 2026-03-04 Common Stock (30000) 30000 Direct

Footnotes

F1: This Form 4/A is being filed to amend the Form 4 filed by the reporting person on January 8, 2020 to (i) attribute the stock option exercise that occurred on January 8, 2020 to the correct Employee Stock Option and (ii) include the appropriate price in column 4 of Table I representing the exercise price of such Employee Stock Option.

F2: The stock option vests 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

F3: The stock option vests 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments. Such options shall continue to vest regardless of whether Mr. de Greef's service with the Company continues